all report title image

DE-IDENTIFIED HEALTH DATA MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

De-identified Health Data Market, By Type of Data (Clinical Data, Genomic Data, Patient Demographics, Prescription Data, Claims Data, Behavioral Data, Wearable and Sensor Data, Survey and Patient-Reported Data, Imaging Data , Laboratory Data, Social Determinants of Health (SDOH) Data, and Others), By Application (Clinical Research and Trials, Public Health, Precision Medicine, Health Economics and Outcomes Research (HEOR), Population Health Management, Drug Discovery and Development, Healthcare Quality Improvement, Insurance Underwriting and Risk Assessment, and Others), By End User (Pharmaceutical Companies, Biotechnology Firms, Healthcare Providers, Insurance Companies/Healthcare Payers, Research Institutions, Government Agencies, and Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)

  • Published In : Nov 2024
  • Code : CMI7476
  • Pages :135
  • Formats :
      Excel and PDF
  • Industry : Healthcare IT

Regional Analysis

De-identified Health Data Market Regional Insights

To learn more about this report, request sample copy

Dominating Region- North America

North America holds a 39.2% share in the de-identified health data market in 2024, driven by advanced healthcare infrastructure, widespread EHR adoption, and supportive privacy regulations like HIPAA (Health Insurance Portability and Accountability Act). The presence of major pharmaceutical companies utilizing de-identified data for drug development, along with significant government and research funding, further strengthens North America’s market leadership.

Fastest-Growing Region- Asia Pacific

Asia Pacific is experiencing rapid growth in the de-identified health data market due to increasing healthcare spending, focus on improving patient outcomes, and growing adoption of advanced technologies. Key countries like China and India are leading the way with investments in healthcare infrastructure, digital health solutions, and AI technologies, driving innovation and expanding access to healthcare services, thus, driving the market growth.

De-identified Health Data Market Outlook for Key Countries

U.S. Dominance in De-Identified Health Data Market Due to its Advanced Healthcare Infrastructure

The U.S. leads the De-identified Health Data Industry due to its advanced healthcare infrastructure, widespread adoption of electronic health records (EHRs), and robust regulatory framework promoting data privacy. For instance, in June 2022, Truveta and Pfizer announced a strategic collaboration to continuously deliver safety insights using real-world, de-identified U.S. health data. Truveta's platform provides Pfizer with up-to-date data to identify, monitor, and evaluate potential signals in near-real time, supporting risk mitigation and further research efforts.

Examining Privacy Implications in Canada’s Virtual Healthcare Landscape

Canada's De-identified Health Data industry is growing due to increasing adoption of digital health platforms. For instance, in September 2022, CCLA, Canadian Civil Liberties Association, launched a report titled Virtual Healthcare Services in Canada: Digital Trails, De-Identified Data and Privacy Implications, led by Dr. Sheryl Spithoff. The study explores privacy concerns within Canada's growing virtual healthcare industry, focusing on data collection, sharing, and the implications of de-identified health information. It examines the potential risks of commercial data use, with privacy policies.

India's Rapid Growth in Digital Health Driven by Strategic Collaborations

India’s de-identified health data industry is growing rapidly due to strategic partnerships. For instance, on November 05, 2024, Monash University and Apollo Hospitals partnered to advance digital health research through data and technology sharing. The partnership grants Monash IT access to Apollo’s de-identified health data from over 200 million patients, enabling AI-driven research to enhance diagnoses and treatments for conditions like cancer, heart disease, and diabetes. This initiative aims to accelerate innovation in healthcare and improve patient outcomes across both India and Australia.

Accelerating Market Growth through Government Initiatives and Technological Advancements in China

China's de-identified health data industry is growing rapidly due to government initiatives like the "Healthy China 2030" plan, which integrates digital health technologies and data analytics into the healthcare system. In July 2023, China’s National Health Commission introduced a policy to encourage the use of de-identified health data for medical research and public health improvement. This initiative promotes collaboration between the private and public sectors, using data analytics to address key health challenges and advance healthcare solutions.

Digital Transformation Enhancing Healthcare Integration in Indonesia

Indonesia is driving de-identified health data sector through new product launches. For instance, in August 2022, Indonesia's Health Ministry launched SATUSEHAT platform, as part of its digital health transformation. It connects over 8,000 health facilities, streamlining patient records and enabling efficient data exchange. The platform integrates with health apps for easy access to medical histories, reducing the need for physical records. This initiative enhances Indonesia’s healthcare system by fostering innovation and improving health data integration across the country.

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.